A prospective survey of febrile events in hematological malignancies.
about
Tuberculosis in patients with haematological malignancies.Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality.Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlaIL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemiaImproving early diagnosis of pulmonary infections in patients with febrile neutropenia using low-dose chest computed tomographySuccessful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry.Neoplastic fever in patients with bone and soft tissue sarcoma.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.The risk of infections in patients with myelodysplastic syndromes in 2016.Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.Prior infections are associated with increased mortality from subsequent blood-stream infections among patients with hematological malignancies.Glucose-6-phosphate dehydrogenase deficiency and risk of invasive fungal disease in patients with acute myeloid leukemia.Predicting early post-chemotherapy adverse events in patients with hematological malignancies: a retrospective study.Infectious complications in chronic lymphocytic leukemia.The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapyRelapsing bloodstream infections during treatment of acute leukemia.
P2860
Q33568467-AA23FED4-FFD7-4A9E-8E39-49EBEF68EB22Q34525373-840166B0-98D7-4240-B7EE-EC92B9479F48Q34667166-002F4D53-9DD0-4EE3-9EEB-B6DBC0C9775CQ35077317-808DBE97-7D96-481B-AF0F-C6E2DA4EA094Q35853686-E60AEE76-033E-40A5-A2EB-E6E1BF573EB7Q36289980-CFC34742-BA6B-48E6-89AD-9C25A94FEE7AQ37139319-0D41D22E-9A87-44F2-AC4D-4A51F5717154Q37406807-5AA3C7D4-A8DB-46C7-975F-F496DF85544FQ38117578-A2DAD0CE-5C1C-4485-BEFD-9F01D42DECECQ38734836-38A6E724-30AE-4E69-9D4A-5425E6C80A42Q38813702-C56E223F-2DF8-40AF-9210-010136445CA3Q38891790-8274C7DD-CEF7-41D6-85B8-64AD22F8872FQ40188573-C6FD7D01-B1BF-4689-B851-B3007C3CD152Q40254512-0809CF41-31CB-4201-AAB3-DE6D640CFF72Q40820446-AE86E3A3-B68F-4D50-B8A5-272AA5606154Q42277456-5D22016F-2E6D-4F13-9714-1FC2431A9044Q42358970-099847E5-C669-4F70-96E8-B77746900D98Q45355151-7F841B84-FFDC-43BF-8370-36CC709E9057
P2860
A prospective survey of febrile events in hematological malignancies.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A prospective survey of febrile events in hematological malignancies.
@en
type
label
A prospective survey of febrile events in hematological malignancies.
@en
prefLabel
A prospective survey of febrile events in hematological malignancies.
@en
P2093
P2860
P50
P1433
P1476
A prospective survey of febrile events in hematological malignancies
@en
P2093
C Cattaneo
Hema e-Chart Group, Italy
M Brugiatelli
P2860
P304
P356
10.1007/S00277-011-1373-2
P577
2011-11-29T00:00:00Z